{"id":"https://openalex.org/W4379875868","doi":"https://doi.org/10.1186/s13023-023-02770-x","title":"Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France","display_name":"Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France","alternate_titles":[],"publication_year":2023,"publication_date":"2023-06-08","ids":{"openalex":"https://openalex.org/W4379875868","doi":"https://doi.org/10.1186/s13023-023-02770-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/37291632","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10249154"},"language":"en","primary_location":{"id":"doi:10.1186/s13023-023-02770-x","doi":"https://doi.org/10.1186/s13023-023-02770-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-023-02770-x","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/s13023-023-02770-x","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4379875868"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/s13023-023-02770-x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028406884","display_name":"Victor Maler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Victor Maler","raw_affiliation_strings":["Pharmacie \u00e0 Usage Int\u00e9rieur, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie \u00e0 Usage Int\u00e9rieur, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]},{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020178294","display_name":"Violette Goetz","orcid":"https://orcid.org/0000-0002-7883-8706","observed_orcids":["https://orcid.org/0000-0002-7883-8706"]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Violette Goetz","raw_affiliation_strings":["Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073988937","display_name":"M. Tardieu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marine Tardieu","raw_affiliation_strings":["Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102643051","display_name":"Abderrahmane El Khalil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Abderrahmane El Khalil","raw_affiliation_strings":["Pharmacie \u00e0 Usage Int\u00e9rieur, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacie \u00e0 Usage Int\u00e9rieur, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]},{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070569386","display_name":"Jean\u2010Meidi Alili","orcid":"https://orcid.org/0000-0003-3988-5494","observed_orcids":["https://orcid.org/0000-0003-3988-5494"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Meidi Alili","raw_affiliation_strings":["Fili\u00e8re G2m, H\u00f4pital Necker-Enfants Malades, APHP, 149 Rue de S\u00e8vres, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fili\u00e8re G2m, H\u00f4pital Necker-Enfants Malades, APHP, 149 Rue de S\u00e8vres, 75015, Paris, France","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Philippe Meunier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Meunier","raw_affiliation_strings":["Fili\u00e8re G2m, H\u00f4pital Necker-Enfants Malades, APHP, 149 Rue de S\u00e8vres, 75015, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fili\u00e8re G2m, H\u00f4pital Necker-Enfants Malades, APHP, 149 Rue de S\u00e8vres, 75015, Paris, France","institution_ids":["https://openalex.org/I1288880153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071681341","display_name":"F. Maillot","orcid":"https://orcid.org/0000-0002-1979-5769","observed_orcids":["https://orcid.org/0000-0002-1979-5769"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210093987","display_name":"Imaging, Brain, and Neuropsychiatry","ror":"https://ror.org/01eem7c55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210093987"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Maillot","raw_affiliation_strings":["INSERM U1253, iBrain, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France","Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1253, iBrain, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210093987"]},{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France","institution_ids":["https://openalex.org/I4210095477"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090854806","display_name":"F. Labarthe","orcid":"https://orcid.org/0000-0001-9788-9667","observed_orcids":["https://orcid.org/0000-0001-9788-9667"]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fran\u00e7ois Labarthe","raw_affiliation_strings":["INSERM U1069, Nutrition, Croissance et Cancer, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France. labarthe@univ-tours.fr","Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France. labarthe@univ-tours.fr","INSERM U1069, Nutrition, Croissance et Cancer, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France"],"raw_orcid":"https://orcid.org/0000-0001-9788-9667","affiliations":[{"raw_affiliation_string":"INSERM U1069, Nutrition, Croissance et Cancer, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France. labarthe@univ-tours.fr","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488"]},{"raw_affiliation_string":"Reference Center for Inborn Errors of Metabolism ToTeM, CHRU de Tours, H\u00f4pital Clocheville, 49 Bd B\u00e9ranger, 37000, Tours, France. labarthe@univ-tours.fr","institution_ids":["https://openalex.org/I4210095477"]},{"raw_affiliation_string":"INSERM U1069, Nutrition, Croissance et Cancer, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Fran\u00e7ois Rabelais de Tours, 10 Boulevard Tonnell\u00e9, 37000, Tours, France","institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5090854806"],"corresponding_institution_ids":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4210095477"],"apc_list":{"value":2790,"currency":"USD","value_usd":2790},"apc_paid":{"value":2790,"currency":"USD","value_usd":2790},"fwci":2.3103,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.85512216,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"18","issue":"1","first_page":"142","last_page":"142"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenylketonuria","display_name":"phenylketonuria","score":0.9729999899864197},{"id":"https://openalex.org/keywords/aspartame","display_name":"aspartame","score":0.9950000047683716},{"id":"https://openalex.org/keywords/phenylalanine-intake","display_name":"phenylalanine intake","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmaceutical-excipients","display_name":"pharmaceutical excipients","score":0.6790000200271606},{"id":"https://openalex.org/keywords/phenylalanine-restricted-diet","display_name":"phenylalanine-restricted diet","score":0.8399999737739563},{"id":"https://openalex.org/keywords/amoxicillin","display_name":"amoxicillin","score":0.746999979019165},{"id":"https://openalex.org/keywords/amoxicillin-clavulanic-acid","display_name":"amoxicillin-clavulanic acid","score":0.9169999957084656},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":0.9850000143051147}],"concepts":[{"id":"https://openalex.org/C2778278337","wikidata":"https://www.wikidata.org/wiki/Q182040","display_name":"Aspartame","level":2,"score":0.9923534393310547},{"id":"https://openalex.org/C2777431362","wikidata":"https://www.wikidata.org/wiki/Q170545","display_name":"Phenylalanine","level":3,"score":0.7336810827255249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5754284262657166},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4370507001876831},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4287897050380707},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3226354122161865},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.20933881402015686},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.18882274627685547},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15897691249847412}],"mesh":[{"descriptor_ui":"D001218","descriptor_name":"Aspartame","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010661","descriptor_name":"Phenylketonurias","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s13023-023-02770-x","doi":"https://doi.org/10.1186/s13023-023-02770-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-023-02770-x","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/s13023-023-02770-x","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10249154","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10249154","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10249154/pdf/13023_2023_Article_2770.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet J Rare Dis","raw_type":"Text"},{"id":"pmid:37291632","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37291632","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet journal of rare diseases","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1747969e84f247b89877c0075e607b4e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1747969e84f247b89877c0075e607b4e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-7 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13023-023-02770-x","doi":"https://doi.org/10.1186/s13023-023-02770-x","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-023-02770-x","pdf_url":"https://ojrd.biomedcentral.com/counter/pdf/10.1186/s13023-023-02770-x","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4379875868.pdf","grobid_xml":"https://content.openalex.org/works/W4379875868.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2117682136","https://openalex.org/W2148805232","https://openalex.org/W2161960007","https://openalex.org/W2166850896","https://openalex.org/W2570496805","https://openalex.org/W2761810763","https://openalex.org/W2889648030","https://openalex.org/W2909667144","https://openalex.org/W3040599267","https://openalex.org/W3131944831","https://openalex.org/W3174804778"],"related_works":["https://openalex.org/W3094528541","https://openalex.org/W3131944831","https://openalex.org/W1987138410","https://openalex.org/W2160507776","https://openalex.org/W2236142242","https://openalex.org/W4403612343","https://openalex.org/W2045841568","https://openalex.org/W2031289870","https://openalex.org/W2419753871","https://openalex.org/W4403611998"],"abstract_inverted_index":{"BACKGROUND:":[0],"Phenylketonuria":[1],"(PKU)":[2],"is":[3,37,55,281],"a":[4,68,117,205,233,272,275,320,338],"rare":[5],"genetic":[6],"metabolic":[7],"disorder":[8],"in":[9,25,57,108,310,324],"which":[10],"especially":[11],"high":[12,144],"phenylalanine":[13],"(Phe)":[14],"concentrations":[15],"cause":[16],"brain":[17,22],"dysfunction.":[18],"If":[19,279],"untreated,":[20],"this":[21,332],"dysfunction":[23],"results":[24],"severe":[26],"microcephaly,":[27],"intellectual":[28],"disability,":[29],"and":[30,95,136,138,153,219,224,245],"behavioral":[31],"problems.":[32],"Dietary":[33],"restriction":[34],"of":[35,40,74,78,86,105,163,192,236,254,264,268,290,327,331],"Phe":[36,91,100,113,129,158,166,182,207,277,308,321],"the":[38,58,84,126,178,199,228,252,262,288,300,325],"mainstay":[39],"PKU":[41,66,311,341],"treatment,":[42],"with":[43,204,274,340],"long-term":[44],"successful":[45],"outcomes.":[46],"Aspartame,":[47],"an":[48,93,260,265,328],"artificial":[49],"sweetener":[50],"sometimes":[51],"added":[52],"into":[53,60,141],"medications,":[54],"metabolized":[56],"gut":[59],"Phe.":[61],"Then,":[62],"patients":[63],"suffering":[64],"from":[65],"on":[67],"Phe-restricted":[69],"diet":[70],"should":[71],"avoid":[72],"consumption":[73],"aspartame.":[75],"The":[76,103,161],"aim":[77],"our":[79],"study":[80],"was":[81,114,131,139],"to":[82,96,134,150,211,232,298,303,318,336],"evaluate":[83],"number":[85,162,235],"drugs":[87,106,164,220,229],"containing":[88,110,165,180,306,322],"aspartame":[89,111,170,179],"and/or":[90,112],"as":[92,259,286],"excipient,":[94],"quantify":[97],"their":[98],"corresponding":[99,127],"intake.":[101,159,278],"METHODS:":[102],"list":[104],"marketed":[107],"France":[109],"established":[115],"using":[116],"national":[118],"medication":[119,323],"database":[120],"called":[121],"\"Theriaque\".":[122],"For":[123],"each":[124],"drug,":[125],"daily":[128],"intake":[130,208,309],"calculated":[132],"according":[133],"age":[135],"weight":[137],"distributed":[140],"3":[142],"categories:":[143],"(>":[145],"40":[146,151],"mg/d),":[147],"medium":[148],"(10":[149],"mg/d)":[152,157],"low":[154,276],"(<":[155],"10":[156],"RESULTS:":[160],"or":[167,187,271,293],"its":[168],"precursor":[169],"remained":[171],"very":[172],"limited":[173,210,231],"(n":[174],"=":[175],"401).":[176],"Among":[177],"drugs,":[181],"intakes":[183],"were":[184,196,209,230],"significant":[185,206,307],"(medium":[186],"high)":[188],"for":[189,198,221],"only":[190],"half":[191],"them":[193],"whereas":[194],"there":[195],"negligible":[197],"others.":[200],"Furthermore,":[201],"these":[202,226,255,269],"medications":[203,305],"few":[212],"pharmaceutical":[213],"classes":[214,227],"(mainly":[215],"antiinfectives":[216],"agents,":[217],"analgesics,":[218],"nervous":[222],"system),":[223],"within":[225],"small":[234],"molecules,":[237,256],"including":[238],"principally":[239],"amoxicillin,":[240],"amoxicillin":[241],"+":[242],"clavulanic":[243],"acid":[244],"paracetamol/":[246],"acetaminophen.":[247],"DISCUSSION:":[248],"In":[249],"situations":[250],"requiring":[251],"use":[253,263,289,304,319],"we":[257,284,296],"propose":[258,285],"alternative,":[261],"aspartame-free":[266,329],"form":[267,273,330],"molecules":[270],"it":[280,314],"not":[282],"possible,":[283],"second-line":[287],"another":[291],"antibiotics":[292],"analgesics.":[294],"Finally,":[295],"have":[297],"remember":[299],"benefits-risk":[301],"balance":[302],"patients.":[312],"Indeed,":[313],"may":[315],"be":[316],"better":[317],"absence":[326],"drug":[333],"rather":[334],"than":[335],"leave":[337],"person":[339],"without":[342],"treatment.":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4379875868","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-06-09T00:00:00"}
